Blunt, Matthew D <br/><br/>
The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  May 2017 
 - 2313-2324 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-16-1662  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Apoptosis--drug effects<br/>B-Lymphocytes--drug effects<br/>Bridged Bicyclo Compounds, Heterocyclic--administration & dosage<br/>Flow Cytometry<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Janus Kinase Inhibitors--administration & dosage<br/>Janus Kinases--antagonists & inhibitors<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Leukocytes, Mononuclear--drug effects<br/>Neoplasm Proteins--genetics<br/>Piperidines<br/>Proto-Oncogene Proteins c-bcr--antagonists & inhibitors<br/>Pyrazoles--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Receptors, Antigen, B-Cell--drug effects<br/>Signal Transduction--drug effects<br/>Sulfonamides--administration & dosage<br/>Sulfones--administration & dosage<br/>Syk Kinase--antagonists & inhibitors<br/>Tumor Microenvironment--drug effects